Qyuns Therapeutics Co., Ltd.

Current Location：Home Investor RelationsDisclosure

Announcements and Circulars

052024.08
NOTICE OF BOARD MEETING

Show More
212024.07
CONTINUING CONNECTED TRANSACTIONS IN RELATION TO THE DEVELOPMENT AND POTENTIAL COMMERCIALIZATION PARTNERSHIP OF QX005N WITH ZHONGMEI HUADONG

Show More
192024.07
DISCLOSEABLE TRANSACTIONS IN RELATION TO SUBSCRIPTION OF WEALTH MANAGEMENT PRODUCTS

Show More
052024.07
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024

Show More
022024.07
DISCLOSEABLE TRANSACTIONS IN RELATION TO SUBSCRIPTION OF WEALTH MANAGEMENT PRODUCTS

Show More
142024.06
VOLUNTARY ANNOUNCEMENT PHASE II CLINICAL TRIAL DATA OF QX005N INJECTION FOR TREATMENT OF PRURIGO NODULARIS (PN) RELEASED AT THE 29TH ANNUAL MEETING OF CHINESE SOCIETY OF DERMATOLOGY

Show More

25 26 27 28 29 30 ... 31